BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Transplant. Sep 18, 2026; 16(3): 122485
Published online Sep 18, 2026. doi: 10.5500/wjt.122485
Figure 5
Figure 5 Distribution of pretransplant donor-specific antibodies mean fluorescence intensity across human leukocyte antigen loci (A, B, C, DR, DQ, DP) and patient follow-up timeline. A: Box plots show locus-specific mean fluorescence intensity values; B: Horizontal timeline plot illustrates individual follow-up duration and outcomes, with markers for death, graft loss, acute rejection, and censoring. HLA: Human leukocyte antigen.


Write to the Help Desk